What Fueled The Previous Growth In The Automated Compounding Devices Market?
The automated compounding devices market has seen considerable growth due to a variety of factors.
• The automated compounding devices market has experienced solid growth in recent years. It is projected to grow from $2.36 billion in 2024 to $2.53 billion in 2025, at a compound annual growth rate (CAGR) of 7.4%.
This growth is attributed to the rising prevalence of chronic diseases, an aging population, expanding healthcare infrastructure, regulatory requirements, and increasing medication errors.
What Is The Expected Growth In The Automated Compounding Devices Market Size Evolve over the Forecast Period?
The automated compounding devices market is expected to maintain its strong growth trajectory in upcoming years.
• The automated compounding devices market is expected to grow significantly, reaching $3.34 billion by 2029, with a CAGR of 7.2%.
This growth is driven by rising cancer prevalence, healthcare expansion, regulatory support, and sustainability efforts. Major trends include telemedicine adoption, AI advancements, healthcare digitalization, and real-time monitoring.
What Main Forces Are Fueling Expansion In The Automated Compounding Devices Market?
The increasing number of personalized medicines is expected to drive the growth of the automated compounding devices market. These devices play a vital role in creating custom medication formulations tailored to individual patient needs. The rising popularity of personalized medicines is due to advancements in genetics and a deeper understanding of patient-specific data. For example, the Personalized Medicine Coalition reported the approval of 16 novel personalized therapies in 2023, compared to 6 in 2022. Hence, the growth of personalized medicines is propelling the automated compounding devices market.
What Are The Primary Segments In The Global Automated Compounding Devices Market?
The automated compounding devices market covered in this report is segmented –
1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software
2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)
2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems
Pre-Book The Automated Compounding Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Automated Compounding Devices Market?
Companies in the automated compounding device market are focusing on robotic compounding technologies to reduce medication errors and improve patient safety. Robotic compounding automates the preparation and mixing of pharmaceutical compounds, ensuring accuracy and safety. For instance, in March 2022, Omnicell Inc., a US-based healthcare tech company, launched the IVX Station, a new automated compounding device. The IVX Station offers faster throughput than traditional systems, improves patient safety, enhances cost efficiency, and ensures compliance with regulatory standards while maintaining a compact design suitable for pharmacies.
Who Are the Key Players In The Automated Compounding Devices Market?
Major companies operating in the automated compounding devices market are:
• McKesson Corporation
• Amerisource Bergen Corporation
• Medtronic PLC
• Becton Dickinson and Company
• Baxter International Inc
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Grifols International S.A.
• Terumo Corporation
• ICU Medical Inc.
• Omnicell Inc.
• Tecan Group Ltd.
• Cantel Medical Corp.
• Fagron N.V.
• Swisslog Healthcare
• ScriptPro LLC
• PharMEDium Services LLC
• Loccioni Group S.p.A.
• ARxIUM Inc.
• Codonics Inc.
• Apexus Inc.
• Equashield LLC
• Yuyama Mfg Co. Ltd.
• Shanghai Weibond Technology Co. Ltd.
• Quirem Medical B.V
What Is The Most Dominant Region In The Automated Compounding Devices Market?
North America was the largest region in the automated compounding devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
